Nitric oxide and the renal patient

Dialysis and Transplantation

Volumn 29, Issue 4, 2000, Pages 174-186

  Orida, Norman K ^b   Lai, Ching San ^a  

^a Medinox Inc   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE DERIVATIVE; CYCLOSPORIN A; ISOENZYME; N(G) METHYLARGININE; N(G) NITROARGININE METHYL ESTER; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NOX 100; UNCLASSIFIED DRUG;

CHROMOSOME 12Q; CHROMOSOME 17Q; CHROMOSOME 7Q; ENZYME LOCALIZATION; HEMODIALYSIS; HUMAN; HYPOTENSION; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; NEPHRITIS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SEPSIS; SIGNAL TRANSDUCTION; VASODILATATION;

EID: 0034077982     PISSN: 00902934     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Williams N. NO news is good news - but only for three Americans. Science 1998; 282:610-611.
2. Kone BC. Nitric oxide in renal health and disease. Am J Kid Dis 1997; 30:311-333.
3. Lane P, Gross SS. Cell signaling by nitric oxide. Semin Nephrol 1999; 19:215-229.
4. Furchgott RE, Vanhoutte PJ. Endothelium-derived relaxing and contracting factors. FASEB J 1989; 3:2007-2018.
5. Knowles RG, Moncada S. Nitric oxide as a signal in blood vessels. Trends in Biochem Sci 1992; 17:399-402.
6. Viinikka L. Nitric oxide as a challenge for the clinical chemistry laboratory. Scand J Clin Lab Invest 1996; 56:577-581.
7. Lane P, Gross SS. Cell signaling by nitric oxide. Semin Nephrol 1999; 19:215-229.
8. 2+/calmodulin-dependent multifunctional protein kinase. J Bio Chem 1990; 265:8975-8978.
9. Griffith TM, Edwards DH, Davies RL, Harrison TJ, Evans KT. EDRF coordinates the behavior of vascular resistance vessels. Nature 1987; 329:442-445.
10. Davies MG, Fulton GJ, Hagen PO. Clinical biology of nitric oxide. Br J Surg 1995; 82:303-326.
11. Cheung PY, Salas E, Schulz R, Randomski MW. Nitric oxide and platelet function: Implications for neonatology. Semin Perinatol 1997; 5:409-417.
12. Randomski MW, Palmer RMJ, Moncada S. Endogenous nitric oxide inhibits human platelet adhesion to vascular endothelium. Lancet 1987; 2:1057-1058.
13. Schultz PJ, Raij L. Endogenously synthesized nitric oxide prevents endotoxin induced glomerular thrombosis. J Clin Invest 1992; 90:1718-1725.
14. Clancy RM, Leszczynska-Piziak L, Abramson SB. Nitric oxide: An endothelial cell relaxing factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992; 90:1116-1121.
15. De Groote MA, Fang FC. NO inhibitions: Antimicrobial properties of nitric oxide. Clin Infect Dis 1995; 21(Suppl 2):S162-S165.
16. 2, and peroxynitrite: Footprints of peroxynitrite in vivo. Adv Pharmacol 1995; 34:17-43.
17. Zhu L, Gunn C, Beckman JS. Bactericidal activity of peroxynitrite. Arch Biochem Biophys 1992; 298:452-457.
18. Lundblad RL, Noyes CM, Featherstone GL, Harrison JH, Jenzano JW. The reaction of bovine a-thrombin with tetranitromethane: Characterization of the modified protein. J Biol Chem 1988; 263:3729-3734.
19. Heller B, Wang ZQ, Wagner EF, Radons J, Burkle A, Fehsel K, et al. Inactivation of the poly (ADP-ribose) polymerase gene affects oxygen radical and nitric toxicity in islet cells. J Biol Chem 1995; 270:11176-11180.
20. McKee M, Scavone C, Nathanson JA. Nitric oxide, cGMP, and hormone regulation of active sodium transport. Proc Natl Acad Sci USA 1994; 91:12056-12060.
21. Raij L, Baylis C. Glomerular actions of nitric oxide. Kidney Int 1995; 48:20-32.
22. Kone BC. Localization and regulation of nitric oxide synthase isoforms in the kidney. Semin Nephrol 1999; 19:230-241.
23. Kone BC, Baylis C. Biosynthesis and homeostatic roles of nitric oxide in the normal kidney. Am J Physiol 1997; 272(Renal Physiol. 41):F561-F578.
24. Bachmann S, Bosse HM, Mundel P. Topography of nitric oxide synthesis by localizing constitutive NO synthases in mammalian kidney. Am J Physiol 1995; 268:F885-F898.
25. Tojo A, Welch WJ, Bremer V, Kimoto M, Kimura K, Omata M, et al. Colocalization of demethylating enzymes and NOS and functional effects of methylarginines in rat kidney. Kidney Int 1997; 52:1593-1601.
26. Ujiie K, Yuen J, Hogarth L, Danziger R, Star RA. Localization and regulation of endothelial NO synthase mRNA expression in rat kidney. Am J Physiol 1994; 267:F296-F302.
27. Terada Y, Tomita K, Nonoguchi H, Marumo F. Polymerase chain reaction localization of constitutive nitric oxide synthase and soluble guanylate cyclase messenger RNAs in microdissected rat nephron segments. J Clin Invest 1992; 90:665-669.
28. Morrissey JJ, McCracken R, Kaneto H, Vehaskari M, Montani D, Klahr S. Localization of an inducible nitric oxide synthase mRNA in the normal kidney. Kidney Int 1994; 45:1593-1601.
29. Ahn KY, Mohaupt MG, Madsen KM, Kone BC. In situ hybridization localization of mRNA encoding inducible nitric oxide synthase in rat kidney. Am J Physiol 1994; 267:F748-F757.
30. Furusu A, Miyazaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki O, et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53:1760-1768.
31. Wang JS, Tseng HH, Shih DF, Jou HS, Ger LP. Expression of inducible nitric oxide synthase and apoptosis in human lupus nephritis. Nephron 1997; 77:404-411.
32. Goligorsky MS, Noiri E. Duality of nitric oxide in acute renal injury. Semin Nephrol 1999; 19:263-271.
33. Yu L, Gengaro PE, Niedergerger M, Burke TJ, Schrier RW. Nitric oxide: A mediator in rat tubular hypoxia/reoxygenation injury. Proc Natl Acad Sci USA 1994; 91:1691-1695.
34. Agmon Y, Peleg H, Greenfeld Z, Rosen S, Brezis M. Nitric oxide and prostanoids protect the renal outer medulla from radiocontrast toxicity in the rat. J Clin Invest 1994; 94:1069-1075.
35. Ferrario R, Takahashi K, Fogo A, Badr KF, Munger KA. Consequences of acute nitric oxide synthesis inhibition in experimental glomerulonephritis. J Am Soc Nephrol 1994; 4:1847-1854.
36. Sogawa K, Numayama-Tsuruta K, Ema M, Abe H, Abe M, Fujii-Kuriyama Y, et al. Inhibition of hypoxia-inducible factor 1 activity by nitric oxide donors in hypoxia. Proc Natl Acad Sci USA 1998; 95:7368-7373.
37. Gabbai FB, Boggiano C, Peter T, Kang S, Archer C, Gold DP, et al. Inhibition of inducible nitric oxide synthase intensifies injury and functional deterioration in autoimmune interstitial nephritis. J Immunol 1997; 159:6266-6275.
38. Zhao W, Tilton R, Corbett J, McDaniel ML, Misko TP, Williamson JR, Cross AH, et al. Experimental allergic encephalomyelitis in the rat is inhibited by aminoguanidine, an inhibitor of nitric oxide synthase. J Neuroimmunol 1996; 64:123-133.
39. Gold DP, Schroder K, Powell HC, Kelly CJ. Nitric oxide and the immunomodulation of experimental allergic encephalomyelitis. Eur J Immunol 1997; 27:2863-2869.
40. Andrews BS, Eisenberg RA, Theofilopoulos AN, Izui S, Wilson CB, et al. Spontaneous murine lulus-like syndromes: Clinical and immunopathological manifestations in several strains. J Exp Med 1978; 148:1198-1215.
41. Moyer CF, Strandgerg JD, Reinisch CL. Systemic mononuclear-cell vasculitis in MRL/Mp-lpr/lpr mice. A histologic and immunocytochemical analysis. Am J Pathol 1987; 127:229-242.
42. Weinberg JB, Granger DL, Pisetsky DS, Seldin MF, Misukonis MA, Mason SN, et al. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: Increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine. J Exp Med 1994; 179:651-660.
43. Gilkeson GS, Mudgett JS, Seldin MF, Ruiz P, Alexander AA, Misukonis, MA, et al. Clinical and serologic manifestations of autoimmune disease in MRL-llpr/lpr mice lacking nitric oxide synthase type 2. J Exp Med 1997; 186:365-373.
44. Oates JC, Christensen EF, Reilly CM, Self SE, Gilkeson GS. Prospective measure of serum 3-nitrotyrosinc levels in systemic lupus erythematosus: Correlation with disease activity. Proc Assoc Am Physicians 1999; 111:611-621.
45. Gilkeson G, Cannon C, Oates J, Reilly C, Goldman D, Petri M. Correlation of serum measures of nitric oxide production with lupus disease activity. J Rheumatol 1999; 26(2):318-324.
46. Website literature at UNOS.org.
47. Wu CJ, Lovett M, Wong-Lee F, Moeller F, Kitamura M, Goralski TJ, et al. Cytokine expression in rejecting cardiac allografts. Transplantation 1992; 54:326-332.
48. Devlin J, Palmer RMJ, Gonde CE, O'Grady J, Heaton N, Tan KC, et al. Nitric oxide generation: A predictive parameter of acute allograft rejection. Transplantation 1994; 58:592-595.
49. Worrall NK, Misko TP, Botney MD, Sullivan PM, Hui JJ, Suau GJ, et al. Time course and cellular localization of inducible nitric oxide synthases expression during cardiac allograft rejection. Ann Thorac Surg 1999; 67:716-722.
50. Worrall NK, Boasquevisque CH, Botney MD, Misko TP, Sullivan PM, Ritter JH, et al. Inhibition of inducible nitric oxide synthase ameliorates functional and histological changes of acute lung allograft rejection. Transplantation 1997; 63:1095-1101.
51. Szabolcs MJ, Ravalli S, Minanov O, Sciacca RR, Michler RE, Cannon PJ. Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. Transplantation 1998; 65:804-812.
52. Mannon RB, Roberts K, Ruiz P, Laubach V, Coffman TM. Inducible nitric oxide synthase promotes cytokine expression in cardiac allografts but is not required for efficient rejection. J Heart Lung Transplant 1999; 18:819-827.
53. Russell ME, Wallace AF, Wallace AB, Wyner LR, Newell JB, Karnovsky M. Upregulation and modulation of inducible nitric oxide synthase in rat cardiac allografts with chronic rejection and transplant arteriosclerosis. Circulation 1995; 92:457-464.
54. Shears LL, Kawaharada N, Tzeng E, Billiar TR, Watkins SC, Kovesdi I, et al. Inducible nitric oxide synthase suppresses the development of allograft arteriosclerosis. J Clin Invest 1997; 100:2035-2042.
55. Koglin J, Glysing-Jensen T, Mudgett JS, Russell ME. Exacerbated transplant arteriosclerosis in inducible nitric oxide-deficient mice. Circulation 1998; 97:2059-2065.
56. Akita K, Dustiong GJ, Hickey H. Suppression of nitric oxide production by cyclosporinc A and FK 506A in rat vascular smooth muscle cell. Clin Exp Pharmacol Physiol 1994; 21:231-233.
57. Marumo T, Nakaki T, Hishikawa K, Suzuki H, Kato R, Saruta T. Cyclosporine A inhibits nitric oxide synthase induction in vascular smooth muscle cells. Hypertension 1995; 25:764-768.
58. Hibbs JB Jr, Westenfelder C, Taintor R, Vavrin Z, Kablitz C, Baranowski RL, et al. Evidence for cytokine-inducible nitric oxide synthesis from L-arginine in patients receiving interleukin-2 therapy. J Clin Invest 1992; 89:867-877.
59. Bone RD. Gram-positive organisms and sepsis. Arch Intern Med 1994; 154:26-34.
60. Wenzel RP. The mortality of hospital acquired infections: Need for a new vital statistics? Int J Epidemiol 1988; 17:225-227.
61. U.S. Renal Data System. USRDS 1999 Annual Data Report. Bethesda, MD: National Institutes of Health, April 1999.
62. Powe NR, Jaar B, Furth SL, Hermann J, Briggs W. Septicemia in dialysis patients: Incidence, risk factors, and prognosis. Kidney Int 1999; 55:1081-1090.
63. Nava E, Palmer RMJ, Moncada S. The role of nitric oxide in endotoxin shock: Effects of L-NMMA. J Cardiovasc Pharmacol 1992; 20(Suppl):S132-S134.
64. Tracey WR, Tse J, Carter G. Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: Pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 1995; 272:1011-1015.
65. Wei XQ, Charles IG, Smith A, Ure J, Feng GJ, Huang FP, et al. Altered responses in mice lacking inducible nitric oxide synthase. Nature 1995; 375:408-411.
66. Szabo C, Mitchell JA, Thiemermann C, Vane JR. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol 1993; 108:786-792.
67. Avontuur JA, Tultein, Nolthenius RP, van Bodegom JW, Braining HA. Prolonged inhibition of nitric oxide synthesis in severe septic shock: A clinical study. Crit Care Med 1998; 26:660-667.
68. Grover R, Zaccardelli D, Colice G, Buntupalli K, Watson D, Vincent JL. An open-label dose escalation study of the nitric oxide synthase inhibitor, N(G)-methyl-L-arginine hydrochloride (546C88), in patients with septic shock. Crit Care Med 1999; 27:913-922.
69. Glaxo Wellcome press release, April 24, 1998.
70. Henrich WL. Hemodynamic instability during hemodialysis. Kidney Int 1986; 30:605-612.
71. Amerling A, Cu GA, Dubrow A, Levin NW, Osherhoff RJ. Complications during hemodialysis. In: Clinical Dialysis (3rd Ed), Nissenson AR, Fine RN, Gentile, DE (eds.). Norwalk, CT: Appleton & Lange, 1993, pp 235-263.
72. Daugirdas JT. Dialysis hypotension: A hemodynamic analysis. Kidney Int 1991; 39:233-246.
73. Leunissen KML, Noordzu TC, van Hoof JP. Pathophysiologic aspects of plasma volume preservation. Contrib Nephrol 1990; 78:201-211.
74. Wehle B, Asaba H, Castenfors J, Furst P, Gunnarsson B, Shaldon S, et al. Hemodynamic changes during sequential ultrafiltration and dialysis. Kidney Int 1979; 14:411-418.
75. Bergstrom J, Asaba H, Furst P. Dialysis ultrafiltration and blood pressure. Proc Eur Dial Transplant Assoc 1976; 13:293-300.
76. Henderson LW, Koch KM, Dinarello CA, Shaldon S. Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1983; 1:3-8.
77. Beasley D, Brenner BM. Role of nitric oxide in hemodialysis hypotension. Kidney Int 1993; 42(Suppl 38):S96-S100.
78. Noris M, Benigni A, Boccardo P, Aiello S, Gaspari F, Todeschini M, et al. Enhanced nitric oxide synthesis in uremia: Implications for platelet dysfunction and dialysis hypotension. Kidney Int 1993; 44:445-450.
79. Yokokawa K, Mankus R, Saklayen MG, Kohno M, Yasunari K, Minami M, et al. Increased nitric oxide production in patients with hypotension during hemodialysis. Ann Int Med 1995; 123:35-37.
80. Lin SH, Chu P, Yu FC, Diang LK, Lin YF. Increased nitric oxide production in hypotensive hemodialysis patients. Am Assoc Artif Intern Organs J 1996;42:M895-899.
81. Kang ES, Acchiardo SR, Wang YB, Tevlin MT, Hughes T, Cardoso S. Hypotension during hemodialysis: Role for nitric oxide. Am J Med Sci 1997; 313:138-146.
82. Martensson L, Hegbrant J, Thysell H. Generation of nitrate during dialysis as a measure of nitric oxide synthesis. Artif Organs 1997; 21:163-167.
83. Nishimura M, Takahashi H, Maruyama K, Ohtsuka K, Nanbu A, Hara K, et al. Enhanced production of nitric oxide may be involved in acute hypotension during maintenance hemodialysis. Am J Kidney Dis 1998; 31:809-817.
84. Yokokawa K, Takara H, Kohno M, Mandal AK, Yanagisawa M, Takeda T. Heparin regulates endothelin production through endothelium-derived nitric oxide in human endothelial cells. J Clin Invest 1993; 92:2080-2085.
85. Lonnemann G, Bingel M, Floege J, Koch KM, Shaldon S, Dinarello CA. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Kidney Int 1988; 33:29-35.
86. Amore A, Bonaudo R, Ghigo D, Arese M, Costamanga C, Cirina P, et al. Enhanced production of nitric oxide by blood-dialysis membrane interaction. J Am Soc Nephrol 1995; 6:1278-1283.
87. Vallance P, Leone A, Calver A, Collier J, Moncada S. Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure. Lancet 1992; 339:572-575.
88. Schmidt RJ, Dominco J, Samsell LS, Yokota S, Tracy TS, Sorkin MI, et al. Indices of activity of the nitric oxide system in hemodialysis patients. Am J Kidney Dis 1999; 34:228-234.
89. Viidas U, Ahlmen J, Hedner T, Dajdahl K, Larsson A, Petterson A, et al. Nitric oxide and blood pressure in normotensive patients on chronic hemodialysis. Dial Transpl 1998; 27:714-724.
90. Nussler AK, Billiar TR. Inflammation, immunoregulation, and inducible nitric oxide synthase. J Leukocyte Biol 1993; 54:171-178.
91. Kang ES, Tevlin MT, Wang YB, Chiang TM. Cardenas R, Myers LK, et al. Hemodialysis hypotension: Interaction of inhibitors, iNOS, and the interdialytic period. Am J Med Sci 1999; 317:9-21.
92. Menezes J, Hierholzer C, Watkins SC, Lyons V, Peitzman AB, Billiar TR, et al. A novel nitric oxide scavenger decreases liver injury and improves survival after hemorrhagic shock. Am J Physiol 1999; 277(Gastrointest Liver Physiol 40):G144-G151.
93. Dickinson E, Tuncer R, Nadler E, Boyle P, Alber S, Watkins S, et al. NOX, a novel nitric oxide-scavenger, reduces bacterial translocation in rats after endotoxin challenge. Am J Physiol 1999; 277(Gastrointest Liver Physiol 40):G 1281-G1287.
94. Roczniak A, Zimpelmann J, Burns KD. Effect of dietary salt on neuronal nitric oxide synthase in the inner medullary collecting duct. Am J Physiol 1998; 275:F46-F54.
95. Wilcox CS, Welch WJ, Murad F, Gross SS, Taylor G, Levi R, et al. Nitric oxide synthase in macula densa regulates glomerular capillary pressure. Proc Natl Acad Sci USA 1992; 89:11993-11997.
96. Kishimoto J, Spurr N, Liao M, Lizhi L, Emson P, Xu W. Localization of brain nitric oxide synthase (NOS) to human chromosome 12. Genomics 1992; 14:802-804.
97. Kashem A, Endoh M, Yano N, Yamauchi F, Nomoto Y, Sakai H. Expression of inducible NOS in human glomerulonephritis: The possible source is infiltrating mnocytes/macrophages. Kidney Int 1996; 50:392-399.
98. Chartrain NA, Geller DA, Koty PP, Sitrin NF, Nussler AK, Hoffman EP, et al. Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. J Biol Chem 1994; 269:6765-6772.
99. Furusu A, Miyazaki M, Abe K, Tsuksaki S, Shioshita K, Sasaki O, et al. Expression of endothelial and inducible nitric oxide synthase in human glomerulonephritis. Kidney Int 1998; 53:1760-1768.
100. Marsden PA, Heng HH, Scherer SW, Stewart RJ, Hall AV, Shi XM, et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem 1993; 268:17478-17488.